Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies

被引：0
|
作者：
Ijeoma Adaku Umelo
Brunella Costanza
Vincent Castronovo
机构：
[1] University of Liège,Metastasis Research Laboratory, GIGA
来源：
Cancer and Metastasis Reviews | 2018年 / 37卷
关键词：
Cancer biomarker; Precision medicine; “omics”; Accessible proteins;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The discovery of biomarkers able to detect cancer at an early stage, to evaluate its aggressiveness, and to predict the response to therapy remains a major challenge in clinical oncology and precision medicine. In this review, we summarize recent achievements in the discovery and development of cancer biomarkers. We also highlight emerging innovative methods in biomarker discovery and provide insights into the challenges faced in their evaluation and validation.
引用
收藏
页码：125 / 145
页数：20
相关论文
共 50 条
  • [1] Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies
    Umelo, Ijeoma Adaku
    Costanza, Brunella
    Castronovo, Vincent
    CANCER AND METASTASIS REVIEWS, 2018, 37 (01) : 125 - 145
  • [2] Innovative proteomic approaches for cancer biomarker discovery
    Faca, Vitor
    Krasnoselsky, Alexei
    Hanash, Samir
    BIOTECHNIQUES, 2007, 43 (03) : 279 - +
  • [3] Equal access to innovative therapies and precision cancer care
    Agnès Buzyn
    Jean-Yves Blay
    Natalie Hoog-Labouret
    Marta Jimenez
    Frédérique Nowak
    Marie-Cécile Le Deley
    David Pérol
    Christian Cailliot
    Jacques Raynaud
    Gilles Vassal
    Nature Reviews Clinical Oncology, 2016, 13 : 385 - 393
  • [4] Equal access to innovative therapies and precision cancer care
    Buzyn, Agnes
    Blay, Jean-Yves
    Hoog-Labouret, Natalie
    Jimenez, Marta
    Nowak, Frederique
    Le Deley, Marie-Cecile
    Perol, David
    Cailliot, Christian
    Raynaud, Jacques
    Vassal, Gilles
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (06) : 385 - 393
  • [5] Development of an innovative cell based assay for the discovery of novel epigenetic therapies for breast cancer
    Chang, Jianjun
    Martinez, Elisabeth
    CANCER RESEARCH, 2009, 69
  • [6] Evaluation of qPCR curve analysis methods for reliable biomarker discovery: Bias, resolution, precision, and implications
    Ruijter, Jan M.
    Pfaffl, Michael W.
    Zhao, Sheng
    Spiess, Andrej N.
    Boggy, Gregory
    Blom, Jochen
    Rutledge, Robert G.
    Sisti, Davide
    Lievens, Antoon
    De Preter, Katleen
    Derveaux, Stefaan
    Hellemans, Jan
    Vandesompele, Jo
    METHODS, 2013, 59 (01) : 32 - 46
  • [7] Cancer Biomarker Discovery for Precision Medicine: New Progress
    Zou, Jinfeng
    Wang, Edwin
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (42) : 7655 - 7671
  • [8] Impact of hemolysis on multiomic pancreatic cancer biomarker discovery: De-risking precision medicine biomarker development
    Kiebish, Michael A.
    Shah, Punit
    Bussberg, Valerie
    Tolstikov, Vladimir
    Searfoss, Rick
    Ofori-Mensa, Kennedy
    Grund, Eric M.
    Darkwah, Abena
    Chen, Emily Y.
    Greenwood, Bennett
    Ntoso, Ellaine Adu
    Rodrigues, Leonardo
    Liu, Mia
    Granger, Elder
    Bountra, Chas
    Sarangarajan, Rangaprasad
    Moser, A. J.
    Narain, Niven R.
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Emerging methods and techniques for cancer biomarker discovery
    Dakal, Tikam Chand
    Dhakar, Ramgopal
    Beura, Abhijit
    Moar, Kareena
    Maurya, Pawan Kumar
    Sharma, Narendra Kumar
    Ranga, Vipin
    Kumar, Abhishek
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
  • [10] Evaluation of computer methods for biomarker discovery on computational grids
    Tonini, Gustavo
    Siqueira, Frank
    ELECTRONIC JOURNAL OF BIOTECHNOLOGY, 2013, 16 (05):
12345